对所有类型的循环利尿剂进行慢性心力衰竭的比较:系统审查和网络元分析的方案
Sami Taleghani1, Jasmin Dam Lukoschewitz1, Sandra Tonning1
1Department of Cardiology, Copenhagen University Hospital-Amager-Hvidovre Hospital, Copenhagen, Denmark.
Acta anaesthesiologica Scandinavica
|February 17, 2025
概括
本系统性综述将慢性心力衰竭 (CHF) 患者的循环利尿剂进行比较,以找到对堵塞的最佳治疗方法. 它旨在确定哪种利尿剂在治疗心血管疾病症状和改善存活率方面提供最佳结果.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 基于证据的医学基于证据的医学.
背景情况:
- 慢性心力衰竭 (CHF) 患者患有堵塞,导致呼吸障碍和,这会使结果恶化.
- 循环利尿剂对于管理塞和维持CHF的液体平衡至关重要.
- 富洛塞米德是常用的,但其他循环利尿剂可能会提供优势.
研究的目的:
- 系统地比较慢性心力衰竭患者所有类型的循环利尿剂.
- 评估不同循环利尿剂在管理CHF相关拥堵方面的疗效和安全性.
主要方法:
- 系统审查协议遵循柯克兰手册和PRISMA-P指导方针.
- 包括随机临床试验 (RCT),将循环利尿剂相互比较,安慰剂或心血管疾病患者的标准护理.
- 从2025年2月开始,对主要医疗数据库 (Medline,Embase,Cochrane Central) 进行全面搜索.
主要成果:
- 主要结局:全因死亡率.
- 二次结果:全因住院治疗,严重不良事件 (SAE) 和体重变化.
- 使用传统的元分析,试验序列分析 (TSA) 和网络元分析进行分析.
结论:
- 该审查将提供循环利尿剂用于CHF管理的全面比较.
- 这些发现将为临床实践提供关于优化尿剂选择和改善患者治疗结果的信息.
- 使用GRADE和CINEMA方法评估证据确定性将指导建议.
相关概念视频
01:22Heart Failure Drugs: Diuretics
334
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
334
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
01:26Heart Failure Drugs: Inotropic Agents
500
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
500
01:22Heart Failure Drugs: β-Blockers
308
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
308
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
439
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
439